On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
62° Feels Like: 62°
Wind: SE 0 mph Past 24 hrs - Precip: 0.01”
Current Radar for Zip

Tonight

Partly Cloudy 53°

Tomorrow

Partly Cloudy 77°

Thurs Night

Isolated Thunderstorms 55°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

AstraZeneca pays $50 million for rights to Merck cancer drug

(Reuters) - Merck & Co Inc has licensed its experimental cancer drug to AstraZeneca Plc for a $50 million upfront fee in a deal that shows Britain's second-biggest drugmaker continuing to rebuild its pipeline.

Under the terms of the agreement, Merck, the No. 2 U.S. drugmaker, will also be eligible to receive future payments related to development and regulatory milestones, as well as tiered royalties.

The drug, MK-1775, is currently in mid-stage trials in combination with standard-of-care therapies for the treatment of patients with certain types of ovarian cancer.

(Reporting by Shailesh Kuber; Editing by Sreejiraj Eluvangal)

Comments